Počet záznamů: 1  

HPMA-based polymer conjugates for repurposed drug mebendazole and other imidazole-based therapeutics

  1. 1.
    SYSNO ASEP0545100
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevHPMA-based polymer conjugates for repurposed drug mebendazole and other imidazole-based therapeutics
    Tvůrce(i) Studenovský, Martin (UMCH-V) RID, ORCID
    Rumlerová, Anna (UMCH-V)
    Kostka, Libor (UMCH-V) RID, ORCID
    Etrych, Tomáš (UMCH-V) RID, ORCID
    Číslo článku2530
    Zdroj.dok.Polymers. - : MDPI
    Roč. 13, č. 15 (2021)
    Poč.str.14 s.
    Jazyk dok.eng - angličtina
    Země vyd.CH - Švýcarsko
    Klíč. slovamebendazole ; drug delivery ; drug repurposing
    Vědní obor RIVCD - Makromolekulární chemie
    Obor OECDPolymer science
    CEPGA19-01417S GA ČR - Grantová agentura ČR
    GA19-05649S GA ČR - Grantová agentura ČR
    LTAUSA18083 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    Způsob publikováníOpen access
    Institucionální podporaUMCH-V - RVO:61389013
    UT WOS000682200100001
    EID SCOPUS85111635782
    DOI10.3390/polym13152530
    AnotaceRecently, the antitumor potential of benzimidazole anthelmintics, such as mebendazole and its analogues, have been reported to have minimal side effects, in addition to their well-known anti-parasitic abilities. However, their administration is strongly limited owing to their extremely poor solubility, which highly depletes their overall bioavailability. This study describes the design, synthesis, and physico-chemical properties of polymer-mebendazole nanomedicines for drug repurposing in cancer therapy. The conjugation of mebendazole to water-soluble and biocompatible polymer carrier was carried out via biodegradable bond, relying on the hydrolytic action of lysosomal hydrolases for mebendazole release inside the tumor cells. Five low-molecular-weight mebendazole derivatives, differing in their inner structure, and two polymer conjugates differing in their linker structure, were synthesized. The overall synthetic strategy was designed to enable the modification and polymer conjugation of most benzimidazole-based anthelmintics, such as albendazole, fenbendazole or albendazole, besides the mebendazole. Furthermore, the described methodology may be suitable for conjugation of other biologically active compounds with a heterocyclic N-H group in their molecules.
    PracovištěÚstav makromolekulární chemie
    KontaktEva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358
    Rok sběru2022
    Elektronická adresahttps://www.mdpi.com/2073-4360/13/15/2530
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.